AbbVie will announce its financial results for the first quarter of 2026 on April 29, before the stock market opens. The company will hold a live webcast of its earnings call at 8 a.m. Central time, accessible via its Investor Relations website. AbbVie focuses on innovative medicines in immunology, neuroscience, oncology, and aesthetics. Investors and interested parties can listen live or access the archived session later that day.
SkinMedica, part of Allergan Aesthetics under AbbVie, has launched a Regenerative Science Advisory Board composed of leading skin health experts to guide future innovation. The company also expanded its R&D facility in Irvine, California, integrating...
Big pharmaceutical companies are confronting a $300 billion loss in drug patents by 2030, prompting a surge in acquisitions of mid-size biotech firms with promising drug pipelines. In 2026, biopharma deal values are expected to exceed $250 billion, t...
